1 trial changed in the last 30 days: 0 stopped, 0 with notable changes, 1 with a minor change only.
Trial completed
Also in this update: Final enrollment: 20 participants (planned 24); Primary completion date changed from estimate of Dec 31, 2027 to Jul 18, 2025
Barbara Ann Karmanos Cancer InstitutePhase 1 NCT05556473 Registry history of NCT05556473 on ClinicalTrials.gov (opens the registry)
Updated
| Phase 1 | 1 | |
| Phase 1/2 | 2 | |
| Phase 2 | 7 |
| NCT ID | Title | Condition | Status | Updated |
|---|---|---|---|---|
| Phase 2 | ||||
| NCT06576115 | Gemcitabine, Nab-paclitaxel Plus the TheraBionic P1 (an Amplitude-Modulated… | Metastatic Pancreatic Adenocarcinoma | Recruiting | 2026-08-10 |
| NCT06107738 | Iberdomide and Daratumumab as Maintenance Therapy After an Autologous Stem Cell… | Multiple Myeloma | Recruiting | 2026-06-26 |
| NCT06420167 | DapagliFLOzin in Renal AL Amyloidosis (FLORAL) | Renal AL Amyloidosis | Recruiting | 2026-06-26 |
| NCT07130903 | Amplitude-Modulated Radiofrequency Electromagnetic Fields (AM RF EMF) in Combination With… | Metastatic Colorectal Adenocarcinoma | Recruiting | 2025-11-10 |
| NCT07796126 | Sequential Toripalimab and Paclitaxel in Patients With Head and Neck Squamous Cell Cancer… | Squamous Cell Carcinoma Head and Neck Cancer (HNSCC) | Not Yet Recruiting | 2026-08-31 |
| NCT07735819 | Positron Emission Tomography/Computed Tomography (PET/CT) Imaging in Patients Diagnosed… | Low Grade Glioma | Not Yet Recruiting | 2026-07-30 |
| NCT04479267 | Polatuzumab Vedotin and Combination Chemotherapy for the Treatment of Previously… | Diffuse Large B-Cell Lymphoma | Active, Not Recruiting | 2025-09-29 |
| Phase 1/2 | ||||
| NCT07743086 | Impact of Duffy-null Associated Neutropenia on Chemotherapy Dosing | Solid Tumor Cancer | Not Yet Recruiting | 2026-08-28 |
| NCT03147885 | Selinexor Plus Combination Chemotherapy in Treating Patients With Advanced B Cell… | Diffuse Large B-Cell Lymphoma | Active, Not Recruiting | 2025-09-29 |
| Phase 1 | ||||
| NCT07098299 | Metformin Combined With Chemotherapy and/or Immunotherapy in Solid Malignancies | Advanced Solid Tumor | Recruiting | 2026-07-24 |
| Not applicable | ||||
| NCT07227831 | A Ph II Study of the TheraBionic P1 Device in Subjects With Hormone Positive Breast Cancer | HER2-negative Breast Cancer | Recruiting | 2026-08-26 |
| NCT07343297 | Ask Questions About Clinical Trials | Oncology | Recruiting | 2026-08-06 |
| NCT05738005 | Dietary Reporting In The Amyloidoses | Amyloidosis | Recruiting | 2026-06-26 |
| NCT07436078 | Culturally Adapting an Intervention to Increase Genetic Testing in African American… | Female Breast Cancer | Recruiting | 2026-06-23 |
| NCT07218432 | A Study of the TheraBionic P1 Device in Breast Cancer | Breast Cancer Stage I | Recruiting | 2026-04-21 |
| NCT07118202 | TheraBionic P1 Device in Subjects With Advanced Hepatocellular Carcinoma | Hepatocellular Carcinoma Recurrent | Recruiting | 2026-04-13 |
| NCT03750981 | C.A.P.A.B.L.E. (CrossFit® and Physical Activity: A Better Life Experience) | Cancer Survivors | Recruiting | 2025-11-06 |
| NCT07095114 | A Study of Disappearing Markers for Daily Radiation Treatment Delivery for Breast Cancer… | Ductal Carcinoma in Situ | Recruiting | 2025-09-18 |
| NCT06908629 | Addressing Social Determinants of Health Among Metro Detroit Cancer Survivors | Cancer | Recruiting | 2025-08-26 |
| NCT07042191 | A Provider Intervention to Reduce Financial Toxicity in Patients With Cancer Through… | Healthy | Active, Not Recruiting | 2026-08-06 |
| NCT02178163 | Comprehensive Genomic Analysis in Tissue Samples From Patients With Recurrent or Stage IV… | Recurrent Non-small Cell Lung Cancer | Active, Not Recruiting | 2026-07-29 |
| NCT07672431 | Study of the TheraBionic P1 Device in Patients With Metastatic Triple Negative Breast… | Triple Negative Breast Cancer | Not Yet Recruiting | 2026-06-29 |
| Not specified | ||||
| NCT00935090 | 3'-Deoxy-3'-[18F] Fluorothymidine PET Imaging in Patients With Cancer | Brain and Central Nervous System Tumors | Active, Not Recruiting | 2026-08-10 |
Breast Cancer (5) · Amyloidosis (3) · DLBCL (3) · Multiple Myeloma (3) · Non-Hodgkin Lymphoma (3) · Colorectal Cancer (2) · Follicular Lymphoma (2) · Mantle Cell Lymphoma (2) · Acute Lymphoblastic Leukemia (ALL) (1) · Acute Myeloid Leukemia (AML) (1)